LUND, Sweden, June 04, 2026--(BUSINESS WIRE)--Triomed AB today announced positive results from a prospective, multicenter, randomized, crossover study evaluating steady concentration peritoneal ...
In this study, participants received their standard CAPD treatment during the control arm, whereas in the Carry Life UF arm, one daily 2.5% dextrose exchange was replaced by a Carry Life UF treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results